TELIX Pharmaceuticals Ltd Long-term Investment Intensity
TELIX Pharmaceuticals Ltd long-term investment intensity. TELIX Pharmaceuticals Ltd (TLX) has a Long-term Investment Intensity of 0.3% as of June 2025. Long-term investments of AU$4.06 Million represent 0.3% of total assets of AU$1.19 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See TLX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of TELIX Pharmaceuticals Ltd (2023–2024)
Long-term investment intensity of TELIX Pharmaceuticals Ltd from 2023 to 2024. This chart shows how TELIX Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2023 to 2024. As of June 2025, the intensity stands at 0.3%, reflecting long-term investments of AU$4.06 Million against total assets of AU$1.19 Billion AUD. See TELIX Pharmaceuticals Ltd (TLX) liquidity interval to measure how many days the company can operate on defensive assets alone.
TELIX Pharmaceuticals Ltd Long-term Investment Intensity by Year (2023–2024)
TELIX Pharmaceuticals Ltd long-term investment intensity by year from 2023 to 2024. The table below presents the year-by-year Long-term Investment Intensity for TELIX Pharmaceuticals Ltd from 2023 to 2024, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TELIX Pharmaceuticals Ltd total assets.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 0.4% | AU$6.09 Million | AU$1.52 Billion | ▼ -2.7 pp |
| 2023 | 3.1% | AU$12.26 Million | AU$398.30 Million | — |